SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-005085
Filing Date
2024-02-06
Accepted
2024-02-06 16:05:20
Documents
14
Period of Report
2024-02-01
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 61277
  Complete submission text file 0001493152-24-005085.txt   243723

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE age-20240201.xsd EX-101.SCH 3009
3 XBRL LABEL FILE age-20240201_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE age-20240201_pre.xml EX-101.PRE 22356
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3736
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 24600214
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)